Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,1-hydroxymethyldiphosphonate
2. Disodium (hydroxymethylene)diphosphonate
3. Disodium Methane Hydroxy-diphosphonate
4. Disodium Methane-1-hydroxy-1,1-diphosphonate
5. Hydroxymethanediphosphonic Acid
6. Hydroxymethanediphosphonic Acid, 14c-labeled
7. Hydroxymethanediphosphonic Acid, Disodium Salt
8. Hydroxymethanediphosphonic Acid, Monosodium Salt
9. Hydroxymethanediphosphonic Acid, Tetrasodium Salt
10. Hydroxymethanediphosphonic Acid, Trisodium Salt
11. Hydroxymethylene Bisphosphonate
12. Methylhydroxydiphosphonate
13. Mhdp
1. 14255-61-9
2. Disodium Methanehydroxydiphosphonate
3. H852yk87wp
4. Sodium (hydroxymethylene)bis(hydrogen Phosphonate)
5. Disodium (hydroxymethylene)diphosphonate
6. Disodium;hydroxy-[hydroxy-[hydroxy(oxido)phosphoryl]methyl]phosphinate
7. Oxidronate Sodium
8. Sodium Oxidronate
9. Oxidronic Acid Sodium Salt
10. Unii-h852yk87wp
11. Oxidronate Disodium [ii]
12. Dtxsid80931520
13. Oxidronate Sodium [vandf]
14. Oxidronate Disodium [mart.]
15. Oxidronate Disodium [who-dd]
16. Oxidronic Acid Sodium Salt [mi]
17. (hydroxymethylen)diphosphonsaeure Dinatriumsalz
18. A937799
19. Phosphonic Acid, (hydromethylene)bis-, Disodium Salt
20. Q27279752
| Molecular Weight | 235.97 g/mol |
|---|---|
| Molecular Formula | CH4Na2O7P2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 235.92276502 g/mol |
| Monoisotopic Mass | 235.92276502 g/mol |
| Topological Polar Surface Area | 141 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 169 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Related Excipient Companies
Market Place
ABOUT THIS PAGE
A Oxidronate disodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxidronate disodium, including repackagers and relabelers. The FDA regulates Oxidronate disodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxidronate disodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxidronate disodium supplier is an individual or a company that provides Oxidronate disodium active pharmaceutical ingredient (API) or Oxidronate disodium finished formulations upon request. The Oxidronate disodium suppliers may include Oxidronate disodium API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxidronate disodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxidronate disodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxidronate disodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxidronate disodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxidronate disodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxidronate disodium suppliers with NDC on PharmaCompass.
Oxidronate disodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxidronate disodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxidronate disodium GMP manufacturer or Oxidronate disodium GMP API supplier for your needs.
A Oxidronate disodium CoA (Certificate of Analysis) is a formal document that attests to Oxidronate disodium's compliance with Oxidronate disodium specifications and serves as a tool for batch-level quality control.
Oxidronate disodium CoA mostly includes findings from lab analyses of a specific batch. For each Oxidronate disodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxidronate disodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxidronate disodium EP), Oxidronate disodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxidronate disodium USP).
LOOKING FOR A SUPPLIER?
